111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
475.28%
Positive growth while JHX shows revenue decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
475.28%
Positive growth while JHX shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-361.30%
EBITDA decline while JHX shows 139.32% growth. Joel Greenblatt would examine position.
-145.42%
EBITDA margin decline while JHX shows 158.36% growth. Joel Greenblatt would examine position.
-361.30%
Operating income decline while JHX shows 123.19% growth. Joel Greenblatt would examine position.
-145.42%
Operating margin decline while JHX shows 140.95% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-26.57%
Tax expense reduction while JHX shows 78.29% growth. Joel Greenblatt would examine advantage.
26.57%
Net income growth 50-75% of JHX's 43.58%. Martin Whitman would scrutinize operations.
-78.00%
Net margin decline while JHX shows 55.00% growth. Joel Greenblatt would examine position.
-100.00%
EPS decline while JHX shows 50.00% growth. Joel Greenblatt would examine position.
-100.00%
Diluted EPS decline while JHX shows 51.06% growth. Joel Greenblatt would examine position.
-100.00%
Both companies reducing share counts. Martin Whitman would check patterns.
-100.00%
Diluted share reduction while JHX shows 0.12% change. Joel Greenblatt would examine strategy.
